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THE FUTURE OF HEALTH CARE: WE ARE OUR OWN
WORST ENEMIES
Nelson J. Dunlap*
The only thing that is constant is change. - Heraclitus
ABSTRACT
Mobile medical applications are increasingly taking center-stage in
the health care industry and more importantly, in the patient-doctor
relationship. Yet, as technological prevalence continues its upward trend,
regulatory initiatives will also continue their march to the forefront of the
discussion. This can lead to only one ultimate conclusion: an impasse
between the potential for technological innovation and governmentally
enforced restrictions. The first, of what will most likely prove to be many,
federal regulation controlling mobile medical applications was recently
enacted by the Food and Drug Administration. Overbearing governmental
regulations such as these stifle innovation in the health care field and
operate to the detriment of the public as a whole by restricting society's
ability to advance in the health care industry. Before implementing any
governmental regulation, a cost-benefit analysis should always be
performed to ensure that it is truly worth it. In the situation where health
care is on one side of the equation, we simply can't afford to stifle our own
future. This can be, quite literally, a matter of life or death.

* J.D. Candidate, May 2015, DePaul University College of Law
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I. INTRODUCTION
Technology has effectively permeated every facet of society and
enhanced the quality of life exponentially. Technological advances are
constantly propelling society forward, keeping individuals on the brink of
discovery and innovation. Society's collective knowledge base is being
continuously updated with new findings, new gadgets to disseminate these
findings, and new ideas that will push the envelope even further. But, as
classical science has proven, for every positive action, there is a negative
and equal reaction. For all of our unbridled and untapped potential to
accomplish and create great things through innovation, the ever-lurking
fear of abuse reigns supreme. The fact of the matter is the only
impediment that stands in the way of true innovation is human
interference.
Presently, the dialogue occurring in health and legal professional
circles across the United States of America is centered on health care. A
different conversation needs to be had that focuses on the burgeoning field
of m applications ("apps") and the role that they will play in the future.
With increasing numbers of doctors and medical students using
smartphones and associated applications as a source of reference material
in daily clinical care, this is not a topic to be overlooked.' The federal
government has taken notice of this marked increase in use of mobile
technology in the health care industry and has responded accordingly by
issuing FDA regulations on the topic. 2 On September 23, 2013, the U.S.

Food and Drug Administration issued final guidance for developers of
mobile medical applications. 3 While the FDA's stated purpose is to focus
its oversight only on mobile medical apps that transform a mobile platform
into a regulated medical device, this is simply another occurrence in a long
line of government-imposed regulations that have the impact of stifling
creativity and innovation. 4 Change is inevitable and progress is beneficial.
It is with virtually little dispute that government regulation is a necessary
component of a properly functioning society, but when those regulations
begin to repress advancement, a cost-benefit analysis must occur. In
today's day and age, the health care provider paradigm is rapidly
transitioning to a model that incorporates mobile technology as the most
I

Benjamin Jelle Visser & Jonathan Bouman, There's a Medical App for That, MEDSCAPE (2012),

http://www.medscape.com/viewarticle/763009 1
2 FDA Issues Final Guidance on Mobile Medical Apps, U.S. FOOD & DRUG ADMIN. (Sept. 23, 2013),

http://www.fda.gov/NewsEventsfNewsroom/PressAnnouncementslucm369431 .htm.
3 Id.
4 Id.
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effective way to provide the best care. So the question becomes, at what
point do the theoretical benefits of government intervention no longer
outweigh the actual benefits of technological advancement?
Part 1I of this Note reviews and discusses the regulations
disseminated by the Food and Drug Administration, in regards to mobile
medical applications, in its most recent guidance. Part III analyzes the
implications that these regulations will have on future innovation in the
health care industry by stifling creativity with overbearing and
unnecessary governmental intervention and oversight. Part IV then gives a
brief overview of the current state of health technology affairs by
highlighting a few of the current prevalent technologies that could also fall
victim to the repression of innovation as a result of future legislation. This
Note concludes that overbearing regulations on innovation in the health
care field operate to the detriment of the public as a whole because they
restrict society's ability to advance in the field of health care by
disincentivizing market entry.
II. OVERVIEW OF FDA RESTRICTIONS
The federal government has been taking precautionary steps towards
regulating the mobile device segment of the health care industry for a
number of years. On April 2 7 th , 2009, the U.S. government released
federal regulations that deal with the ways in which protected health
information should be maintained, which steps should be taken to prevent
a data breach, and how to act in such a case. 5 These guidelines were
submitted to the federal register by the Department of Health and Human
Services (HHS). 6 However, that document was simply guidance, and a
request for comments under § 13402 of the Health Information Technology
for Economical and Clinical Health Act (HITECH). 7 Those regulations did
not deal with issues related to storage of protected health information in
medical applications, so the FDA was tasked with the responsibility of
filling the void.8
The Food and Drug Administration, in its issuance of final rules
governing the development and oversight of health-related apps, reiterated
that its focus of the guidance is on the apps that could be harmful if

5 MEDSCAPE, supra note 1.
6 74 Fed. Reg. 19,006.
7 Id.
8 MEDSCAPE, supra note 1.
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defective or misused. 9 It is worth noting that while this guidance issued by
the FDA is nothing more than a nonbinding recommendation, the FDA
carries enough weight behind it that recommendations are viewed as akin
to legislative action.' 0 The guidance issued outlines the FDA's tailored
approach to mobile apps.ll To be more specific, the FDA opines that it is
only regulating products that turn smartphones into devices that the FDA
already regulates.1 2 The problem with this approach is that to the untrained
eye, referring to a regulation as "tailored" would seem to imply that it is
narrow in scope. However, a more detailed look at the potentially
expansive nature of this guidance may reveal a different conclusion.
The FDA intends to exercise enforcement discretion for the majority
of mobile apps that exist, as they pose a minimal risk to consumers.' 3 This,
in turn, means that the FDA will not enforce requirements under the
Federal Drug & Cosmetic Act. 14 This oversight on mobile medical apps
focuses on apps that fit primarily into two categories.' 5 The first being
mobile medical apps that are intended to be used as an accessory to a
regulated medical device.1 6 For example, an application that allows a
health care professional to make a specific diagnosis by viewing a medical
image from a picture archiving and communication system on a tablet or
smartphone would qualify for oversight. 17 The second category is
comprised of applications that transform a mobile platform into a
regulated medical device.1 8 An example of one such device would be an
application that turns a smartphone into an electrocardiography machine
(ECG) that would detect abnormal heart rhythms or determine if a patient
is experiencing a heart attack. 19 The one other category that FDA's
guidance touches on is comprised of mobile apps that display, transfer,
store, or convert patient-specific medical device data from a connected

9 Elizabeth Armstrong Moore, FDA to Start Reining in the Wild West of Medical Apps, CNET.com (Sept.
23,
2013),
http://news.enet.com/8301-11386_3-57604236-76/fda-to-start-reining-in-the-wild-west-ofmedical-apps/.
10 Mobile Medical Applications: Guidancefor Industry and Food and Drug Administration Staff U.S.
FOOD & DRUG ADMIN. (Sept. 25, 2013), http://www.fda.gov/downloads/MedicalDevices/

DeviceRegulationandGuidance/GuidanceDocuments/UCM263366.pdf.
11 FDA, supra note 2.

12 Moore, supra note 9.
13 FDA, supra note 2.
14 Id.
15 Id
16 Id.
17 Id.

18 Id.
19 FDA, supra note 2.
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device, and therefore are mobile medical apps. 20 One such example would
be a mobile app that connects to a nursing central station and displays
medical device data to a physician's smartphone or tablet. 21
While the FDA will not regulate the sale of hardware, such as tablets
or smartphones, or even the personal use of basic wellness apps like
medical dictionaries, pedometers, or heart rate monitors, the FDA will
instead regulate those apps that have the most room to grow in regards to
social utility. 22 Dr. Jeffrey Shuren, the director of the FDA's Center for
Devices and Radiological Health, stated that in regards to the regulations,
"it's not about the platform," but rather, "it's about the functionality. An
ECG is an ECG.",23 Dr. Shuren also stressed that "some mobile apps carry
minimal risks to consumer or patients, but others can carry significant
risks if they do not operate correctly." 24 It is this potential for significant
risk that is the motivating factor behind the FDA's final guidance.
The FDA itself has acknowledged that mobile apps have the potential
to transform health care by allowing doctors to diagnose patients with
potentially life-threatening conditions outside of traditional health care
settings. 2 5 The FDA further concedes that these mobile apps also have the
possibility of helping consumers manage their own health and wellness as
well as gain access to useful information whenever and wherever
consumers need it. 26 Although Dr. Shuren asserted that, "the FDA's
tailored policy protects patients while encouraging innovation," the latter
half of that statement has yet to be seen.2 7
III. FDA REGULATIONS IMPLICATION ON FUTURE
INNOVATION
The United States of America has a long and rich history of
government-imposed regulations that have the effect of suppressing
further innovation and growth. This is typically done for good reason, with
the overall benefit to society in mind. However, as with any system, there
is bound to be an instance of governmental overreach that goes beyond the
20 U.S.

FOOD & DRUG

ADMIN.,

Medical Devices: Example of MMAs

http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ConnectedHealth/
MobileMedicalApplications/ucm368743.htm (last updated Sept. 23, 2013).
21 Id.
22 Moore, supra note 9.
23 Id.
24 FDA, supranote 2.
25 Id.
26Id.
27 Id.

the

FDA Regulates
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purported purpose and in turn, has a deleterious and unintended
consequence. The stifling of future innovation in the mobile medical app
market is one such consequence. Even the President of the United States
himself has expressed how imperative it is for any regulatory scheme that
28
is put in place to take future innovation into consideration.
On their face, the regulations promulgated by the FDA could serve
to constrict a market that is on the cusp of explosive growth. Mobile
application developers have begun to enable the mobile health industry to
successfully monetize their services. 29 The market for mobile health
services has now entered the commercialization phase and is projected to
reach $26 billion globally by 2017.30 This number is even more impressive
when considering that in 2010, it was expected that 500 million
smartphone users worldwide will be using a health care app by 2015.31
The fact of the matter is, market forces are continuing to see trends in an
upward fashion relating to this industry.
With both health care providers and consumers embracing
smartphones as a means to improve health care, and the substantial
projected financial growth that is sure to help an ailing economy, it is
counterintuitive to believe that these regulations are in the best interest of
society.32 The numbers alone tell a tale of widespread public support of
this shift in the industry. As of March 2013, some of the top mobile health
application publishers and developers had managed to generate more than
three million free app downloads and 300,000 paid downloads in the
United States alone, and this only on the 1OS platform. 33 The reach on
other platforms and in other countries differs quite a bit, but the same
study also showed an increase of business potential for mobile health
applications in those markets as well.3 4 In light of how pervasive the
28 See Exec. Order No. 13,563, 76 Fed. Reg. 3,821 (Jan. 18, 2011) (Section 1(a) states:
Our regulatory system must protect public health, welfare, safety, and our environment
while promoting economic growth, innovation, competitiveness, and job creation. It must be
based on the best available science. It must allow for public participation and an open
exchange of ideas. It must promote predictability and reduce uncertainty. It must identify
and use the best, most innovative, and least burdensome tools for achieving regulatory ends.
It must take into account benefits and costs, both quantitative and qualitative. It must ensure
that regulations are accessible, consistent, written in plain language, and easy to understand.
It must measure, and seek to improve, the actual results of regulatory requirements.).
29 Ralf-Gordon Jahns, The Market for mHealth App Services Will Reach $26 Billion by 2017,

RESEARCH2GUIDANCE.COM (Mar. 7, 2013), http://www.research2guidance.com/the-market-for-mhealthapp-services-will-reach-26-billion-by-2017/

30 Id.
31 MEDSCAPE, supranote I.
32 Jahns, supra note 28.

33 Id.
341d.
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mobile medical app industry has become, there is finally evidence that the
long-expected mobile revolution in health care is set to happen. 35 Medical
apps have an enormous potential for improving medical practices by
providing a quick, comprehensive, and up-to-date overview of current
clinical guidelines, which could in turn help clinical decision making and
upside
change the way health care is delivered. It is due to the potential
36
that many market analysts are not surprised by this revolution.
Mobile medical app consumers are present, support of the mobile
medical app market is present, the only obstruction that could bridle the
potential of mobile medical apps is governmental intervention. With every
regulation that is put in place, a disincentive is placed in the market to
inhibit growth. Some commentators have referred to the robust and ever
37
evolving mobile medical apps market as the "Wild West."
Commentators have even gone so far as to comment that the Wild West of
mobile medical apps is getting a little tamer due to the recent FDA
regulations. 38 However, "tame" is a word used to describe an animal that
has been plucked from its natural habitat, and is dwelling under the thumb
of an oppressive authority that intends to control its every move, not let it
function as it was intended. This is no way to nurture a growing industry
with such great potential.
In the mobile medical application development industry, as with
many innovatively- driven fields, apps are created for one of two reasons:
either to address specific purposes that the market indicates it needs or in
response to a developer's creative wants. Governmental regulations
historically and continue to fly directly in the face of creativity. The main
way this is accomplished is simply by the speed, or lack thereof, in which
things move once governmental intervention occurs. The mobile medial
app market is a fast-paced industry that is constantly changing and
morphing to meet the demands of providers and consumers alike. The
health care industry consistently requires flexibility and fast response time
to changes, given the fact that issues could quite literally be matters of life
or death. Yet, government is intentionally constructed to be a slowmoving, deliberate body. We, as a society, expect our governmental bodies
to act in a cautious and calculated fashion to problems as they arise, and
not necessarily reach quick decisions. It is very difficult to reconcile these
two opposing approaches. In fact, out of the thousands of mobile medical
35 Id.
36 MEDSCAPE, supra note I
37 Moore, supra note 9.

38 Id.
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applications that exist, the FDA has approved about 100 apps over the past
decade. 39 Even more telling is that 40 of those 100 apps have been
approved in just the past two years. 40 This can lead the casual observer to
only one logical conclusion: as problems arise in the health care industry
that a mobile medical application could address, the speed with which that
app can be created and implemented will be severely burdened by
government regulation. If a casual observer can readily reach that logical
end, the developers of mobile apps will be able to as well. Profit is realized
by performance, and in a situation where your performance could be
hampered by the slow-moving cogs of a government entity, it pays to
simply develop mobile applications that are not subjected to such
regulations. It is more prudent for top developers to be working on the
next big application that will advance the state of health care, as opposed
to working on the next great children's video game. If developers are not
motivated to push the technological limits in the health care sphere, any
mobile medical app momentum that has accumulated thus far could cease,
leaving the all-important health care industry without the talent it needs to
thrive.
Although the current regulations handed down by the FDA are only
guidance, there is a substantiated fear of a "slippery slope" problem that
comes along with such guidance. The FDA's guidance documents do not
establish legally enforceable responsibilities. 4 1 Instead, guidance describes
the Agency's current thinking on a topic and should be viewed only as
recommendations. 42 These rules begin as mere recommendations and
before long they are being regarded as federal mandates. This is not to say
that the power behind the Food and Drug Administration should be
diminished. Rather, this is to call attention to the likelihood that the
issuance of FDA guidance could very well be the basis for a future
congressional act. Members of the mobile application development
industry are cognizant of the fact that for a federal rule to transition from
simply being an FDA guidance recommendation to being codified as a
statute is not a far reach. The concerns over the impact that these
regulations will have on the growth of mobile medical apps is only
compounded when viewed in the light of those regulations being federal
law. If developers are apprehensive about the ways in which they will be

39 FDA, supra note 2.

40 Id.
41 FDA, supra note 10.

42 Id.
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constrained in the creation of their applications, they are likely to elect not
to wade into those waters, leaving society as a whole to pay the price.
As always, there is an overarching responsibility and concern for
protecting the health care patient. At the core of the movement to improve
care, be it through conventional measures or with innovative technological
advances, the focus is constantly on ways to make the patient experience
better and more effective. While it is important to analyze the impact that
regulations can and will have on innovation in the United States, it is
equally important to understand that the concern for quality patient care as
a whole, is a global concern. The General Medical Council, which sets
standards of professional and ethical conduct that physicians in the United
Kingdom are required to follow, releases a guidance once a year for
4 3 The Good Medical
doctors that is called the Good Medical Practice.
Practice states that "doctors and students must provide a good standard of
practice and care" and keep their professional knowledge and skills up to
date.",44 Granted, The General Medical Council is designed to provide
guidance for the United Kingdom and not the United States, but the
Hippocratic Oath knows no coastal bounds. The question becomes then,
will mobile medical apps provide the user with
up-to-date evidence and
45
care?
health
for
standards
clinical
highest
the
The answer to this question is not readily discernible because the
conversation is truly just beginning. However, as a result of the rapid
growth of the mobile market, some problem areas have already begun to
arise. The growth of this industry has increased the risk of using an app
that is unreliable, not evidence-based, trivial, or even dangerous. 46 For
example, in 2011 the Federal Trade Commission ("FTC") brought charges
against two mobile app companies that had advertised that their
smartphone applications could treat acne.4 7 The FTC alleged that the
mobile apps advertised being able to treat acne with colored lights emitted
from smartphones or mobile devices. 48 Ultimately, the mobile app
marketers settled with the FTC, agreeing to be barred from making certain
health-related claims without scientific evidence. 49 Even more troubling, it
43 MEDSCAPE, supra note t

44 Id.
45 Id.

46 Id.
47 "Acne Cure" Mobile App Marketers Will Drop Baseless Claims Under FTC Settlements. FEDERAL
TRADE COMMISSION, (Sept. 8, 2011). http://www.ftc.gov/news-events/press-releases/2011/09/acne-cure-

mobile-app-marketers-will-drop-baseless-claims-under.
48 Id.
49 Id.
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requires no mental gymnastics to foresee a situation where medical errors
are the direct result or caused by unreliable medical apps that have
50
emerged on the market.
In light of the concern for patient care, yet another question is posed,
what are the remedies or consequences for when one of these risks is
realized? As it stands, if there is an issue with a conventional medical
device or medication, those items can be recalled, but it is yet to be seen if
such can be done with a smartphone app. 5' On the one hand, the
problematic application can be removed from the corresponding app store,
but that will only prevent new medical professionals from downloading
it. 52 The developer is not able to remove the apps from phones directly, so
the users must do it themselves. 53 This leaves open the possibility for the
risk that recalled apps would still be used by doctors, extending the risk to
patients' health.54 The FDA guidance addresses this possible problem only
tangentially. The Agency's guidance details "Medical Device Reporting,"
or adverse event reporting.55 The Medical Device Reporting regulation
requires manufacturers and importers of medical devices to submit reports
to the FDA whenever they receive or otherwise become aware of
information, from any source, that reasonably suggests that a device they
market may have caused or contributed to a death or serious injury.56 This
same reporting requirement extends to when the device has malfunctioned
and the device or a similar device that is on the market would be likely to
cause or contribute to a reportable death or serious injury if the
57
malfunction were to recur.
After the reporting of a perceived problem has been submitted, there
are further steps that must be taken to correct the problem. A mobile
medical app manufacturer may voluntarily take action at any time or may
be requested to take action by the FDA to correct problems. 58 Examples of
the types of actions that a mobile medical app manufacturer may be
requested to take include: inspecting the device for problems, repairing the
device, adjusting the settings on the device, or even upgrading the software

50 MEDSCAPE, supra note I

51
52
53
54
55
56
57

Id.
Id.
Id.
Id.
FDA, supranote 10.
21 C.F.R. § 803.1(a).
Id.

58 FDA, supranote 10.
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to reduce risk from a "bug" or unintended response. 59 Given the fact that
these "requests" may appear to be relatively invasive, the FDA attempts to
assuage the concerns of potential app developers by detailing that when
recommending corrective action, the FDA intends to take into account the
essential role that certain mobile medical apps take as an integral part of a
larger patient care system. 60 In the grand scheme of things, this will do
little to lessen the impact of the notion that the FDA has the final say on a
mobile app. Even further, in accordance with 21 CFR §806.10, mobile
medical app manufacturers are required to promptly report to the FDA
certain actions concerning device corrections and removals for the mobile
medical app within ten working days from the time the correction is
initiated,. 6' "Required to report" no longer sounds like compliance with a
request or even an assent to a simple recommendation; it sounds much
more ominous.
In the delicate ecosystem that is the mobile app industry, the health
care field needs to be able to corral as many developers as possible to
continue advancement. All of these regulations, and many more, are well
founded, but nonetheless restrictive. Regulations such as the FDA's
Mobile Medical Application Guidance, that come across as harsh,
overbearing, and stiff will only act to deter new actors from entering the
field.
IV. CURRENT STATE OF HEALTH TECHNOLOGY AFFAIRS
New and innovative technological advances have the potential for
vastly reshaping the look and feel of the physician-patient dichotomy.
However, the potential for such is not confined solely to the operating and
examining rooms or solely to the advent of mobile medical apps.
Technology in the health care industry has been progressing by leaps and
bounds in recent years and there is no foreseeable end to this amelioration
as long as governmental interference is kept to a minimum. With new
forms of cutting edge technology being made available to consumers on a
daily basis, these advances are bound to become ingrained in the health
care world, and do so to the great benefit of society. Alas, with every step
forward we make on the technological frontier, privacy concerns are ever
present and require governmental oversight.

59 Id.

60 Id
61 Id.
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One of the newest technologies on the forefront of science today is
Google Glass. Google Glass is essentially an Android smartphone that is
void of the actual cellular transmitter, but is capable of running Android
apps and is built into a pair of wearable glasses. 62 While Google Glass is
not fully open to the public yet, beta testers already have begun
hypothesizing about its implications in health care. Some believe that
clinicians should be able to successfully use Google Glass to improve
quality, safety, and efficiency in a manner that is less bothersome to the
patients than previous models of interaction. 63 Some individuals have gone
so far as to consider health care applications that could be utilized on
Google Glass to the benefit of patients and doctors alike. For example,
Google Glass could be utilized to assist a clinician in making the proper
decision. 64 A clinician that is responding to a cardiac arrest could use
Google Glass to retrieve the appropriate decision support for the patient in
question and visually see a decision tree that incorporates optimal doses of
medications, the EKG of the patient, and vital signs. 65 Another envisioned
use for Google Glass has been aiding nurses in their daily routines. A
nurse could put on a pair of Google Glasses, walk into a patient room and
a Wi-Fi enabled locating function could show the nurse a picture of the
patient in the room who should be receiving specific medications and then
pictures of the actual medications. 66 Neither of these two examples have
come to fruition as of yet, but both highlight not only the potential of
Google Glass but also the willingness of individuals to begin the process
of assimilating the technology into the health care realm.
Notwithstanding this potential, it is just as easy to envision the
potential privacy concerns that could be raised by the inclusion of Google
Glass to a medical practice. Given the strong and justified importance that
is placed on patient privacy, governmental oversight is bound to occur.
Furthermore, the oversight would not be as lax as to be administered by
the Food and Drug Administration, but will more than likely be the
byproduct of congressional action. This is, yet again, a predictable
impediment to technological growth as it will act as a barrier to entry into
the field.

62 John Halamka, Five PotentialHealthcare Applications for Google Glass, THE HEALTH CARE BLOG
(July 17, 2013), http://thehealthcareblog.com/blog/2013/07/17/five-potential-healthcare-applications-forgoogle-glass/.

63 Id.
64 Id.

65 Id
661d.
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Impediments to technological growth not only prevent furtherance of
societal advancement, but also act as a disservice to subsections of the
population that could benefit greatly from an increased prevalence of
technology. It has been noted that when mobile medical applications are
appropriately utilized, they possess tremendous potential for improving the
quality and affordability of health care, especially in rural areas of the
country.6 7 All health care is not created equal and there is a substantial
difference between health care access in urban areas as compared to more
rural areas. 68 There are, on average, 57 general physicians per 100,000
residents in rural areas, compared to 78 per 100,000 in urban areas. 69 With
this inequality gap becoming widely known, mobile medical apps have the
potential to help close the gap and subsequently increase quality of care.
When viewed in light of the fact that rural areas tend to have a higher
prevalence of chronic diseases, the potential of mobile medical apps even
more important. 70 Mobile devices and their accompanying apps are
becoming such an indispensable part of everyday life, regardless of rural
or urban setting, that it is incumbent upon society to truly embrace the
substantive good that can come about as a result of mobile app
development. A relatively recent survey by the Pew Internet & American
Life Project found that 31% of cell phone owners use their phone to look
for health or medical information online, which was an increase of 17%
from 2010.71 The combination of large scale public adoption of mobile
devices, paired with the social benefit that mobile medical apps possess
should be justification enough to avoid any tactics that may inhibit
innovation. Even with all of the potential widespread good that mobile

67James G. Kahn et al., Mobile' Health Needs and Opportunities in Developing Countries, 29 HEALTH
AFF. 254, 254 (2010) (finding that there is some evidence that mHealth technology may improve health
care in the developing world, but calling for the structured evaluation of this potential); Warren A. Kaplan,
Can the Ubiquitous Power of Mobile Phones Be Used to Improve Health Outcomes in Developing
Countries?,
GLOBALIZATION
&
HEALTH
(May
23,
2006),

http://www.globalizationandhealth.com/content/2/l/9 (finding that current evidence both supports and
refutes the idea that mHealth technology will improve healthcare outcomes in the developing world).
68 Eric H. Larson & Thomas E. Norris, Rural Demography and the Health Workforce: Interstate
Comparisons, State of the Health Workforce in Rural America: Profiles and Comparisons 23, 26 (2003),
availableat http://depts.washington.edu/uwrhrc/uploads/RuralCh4Comparisons.pdf.
69 Id. at27
70 Larry Gamin et al., Rural Healthy People 2010: A Companion Document to Healthy People 2010, 91
(2003) ("The disproportionate prevalence of chronic disease is reflected in the higher crude all-causes
mortality rates reported for rural areas").
71 Susannah Fox & Maeve Duggan, Mobile Health 2012, PEW INTERNET & AM. LIFE PROJECT 2 (2012),
http://www.pewintemet.org/Reports/2012/Mobile-Health/Key-Findings.aspx ("One in three cell phone
owners (31%) have used their phone to look for health information. In a comparable, national survey
conducted two years ago, 17% of cell phone users had used their phones to look for health advice").
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medical apps may bring, there is an ever-present fear of inadequate
security or insufficient privacy.
Privacy is a justifiable concern in our society today, especially as it
implicates the medical field. Some commentators view privacy and
security concerns as active barriers to successfully utilizing the power of
mobile health applications due to the regulatory oversight that will have to
be enacted.72 Most notably, the concerns center on the storage of personal
health information ("PHI") on mobile phones and then the transferring of
that data over unsecured networks. 73 As it stands, the Health Insurance
Portability and Accountability Act, or HIPAA, governs the regulation of
74
security and privacy standards for electronically transmitted PHI.
Without delving too deeply into HIPAA and its many facets, it is worth
noting that HIPAA established rules for viewing electronic PHI as well as
standardized data transmission requirements.75 Yet, the argument has been
made that these standards are inadequate within the changing landscape of
the health IT environment. 76 For instance, HIPAA does not cover third
party developers whose applications may not have stringent data
protection standards for transmission or storage in compliance with
HIPAA.77 While HIPAA might not have the requisite scope to cover third
party developers, the FDA and any future legislation most certainly will
attempt to pick up where HIPAA left off.
To date, the FDA has narrowed its focus solely to mobile medical
apps that have the potential to transform mobile devices into medical
devices. 78 However, the slippery slope that a privacy-centered rationale
will set this country down is readily foreseeable. While the privacy and

72 Daniel F. Schulke, The Regulatory Arms Race: Mobile-Health Applications and Agency Posturing,93
B.U.L. REV. 1699, 1710 (2013).

73 ld
74 HIPAA delegates authority to HHS to issue regulations on privacy and security standards. See 42 U.S.C.
§ 1320d-9 (2006) (defining the Secretary's power to issue rules concerning the establishment of standards
and requirements for transmitting electronic health information); HIPAA Privacy Rule, 45 C.F.R. §§ 160,
164.102-.106, 164.500-.534 (2012); HIPAA Security Rule, 45 C.F.R. §§ 160, 164.102-106, 164.302-.318
(2012) (establishing national standards to protect electronic personal health information).
75 See 45 C.F.R. §§ 164.302-.318 (establishing security requirements for PHI for electronic and physical
access).
76 Schulke, supra at 1711.
77 HIPAA only applies to covered entities and their business associates. Covered entities are health plans,
healthcare clearinghouses, and healthcare providers who electronically transmit health information. 45
C.F.R. § 160,103; MHealth application developers will need to determine whether their applications will be
used by a covered entity and involve the transmission or storage of PHI. Adam H. Greene, When HIPAA
Applies

to

Mobile Applications,

MOBIHEALTHNEWS

(June

16,

2011),

http://mobihealthnews-

.corn/I 1261/when-hipaa-applies-to-mobile-applications/ (Applications used by patients, however, are not
covered by HIPAA unless a covered entity is involved).
7' Moore, supra note 9.
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security concerns related to PHI on mobile devices are unique to mobile
applications that contain Electronic Health Records (EHRs), and fall
within the purview of HIPAA, those same concerns can be applied to the
new wave of mobile medical applications that the FDA intends to regulate.
Virtually any mobile medical applications that you can think of, will
obtain and store personal information regarding the end-user. That is
simply the nature of mobile applications. Given the fact that these mobile
applications will be used as medical devices, it is clear to see how these
apps could also obtain and store some personal health information. The
fear with EHRs is that if the information is not encrypted, it may be easily
accessible if a provider's device is lost or stolen, hacked, or simply
displayed in an inappropriate location. 79 Even more compelling of a worry
is the notion that if a mobile device has malware or spyware, then the
storage of the unencrypted information on the mobile device poses a
substantial security risk. 80 Neither one of these two concerns are exclusive
to health records. These are legitimate concerns that mobile medical
application developers have to grapple with. The security and privacy of
the applications being developed to address needs in the medical
community are pressing issues as well.
Even in light of ever-rising privacy concerns, overbearing
governmental regulations are not the answer. In order for the app
developers to stay on the forefront of innovation, and ahead of potential
security breaches, it is essential that their creativity to address these
problems is not hampered by unnecessary regulatory oversight. Privacy is
important, but the individuals who can help maintain privacy and security
are the same ones that government intervention tends to stifle.
IV. CONCLUSION
Mobile medical applications have huge potential for expansion
throughout the industry and society as a whole. As long as we, as a
country, continue to push the proverbial envelope and advance the state of
the art of both technology and health care, there will continue to be a
cutting edge intersection between health and technology. It is at this
intersection that a decision must be made. What is the cost of innovation
and are we willing to pay it?

79 Schulke, supra note 68 at 1711.
80 Mobile Device Security: The Insider's Guide. Opinions and Tips from the World-Leading Experts,
MOBITHINKING, http://mobithinking.com/mobile-device-security (last visited Dec. 28, 2013) (interviewing
three experts on the security risks posed by the storage of PHI on mobile phones).
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History has, time and time again, shown that when governmental
intervention occurs, and legislation or agency regulations are
implemented, innovation suffers. This is due in large part to the system of
governance that is in place. The United States governmental structure is
not intended to be a fast-moving body, but rather slow and deliberate. This
inherently results in decisions reached and promulgated a significant
amount of time after the initial issue came to be. With an industry as fastpaced as technology, governmental oversight is bound to be a step behind.
The Food and Drug Administration's most recent guidance on mobile
medical apps is just one, in a long line of examples, of regulations that
have been set forth after an industry or practice is well-established. Mobile
application development has been the newest creative outlet in our society
and has generated massive amounts of product because of this. For the
FDA to wade into these unchartered waters now, and attempt to control the
industry or set seemingly arbitrary standards will be met with opposition
by market forces. The problem being, that the market forces are the app
developers and their opposition will simply be to divert their resources to
the creation of non-medical applications. In today's day and age, we
cannot afford to miss out on the next wave of health-related technological
improvements simply because the government delayed its decision to exert
control. For some portions of the population, this is quite literally a matter
of life or death.
In our society, we have a propensity to capitalize on any burgeoning
field and to then regulate said field. Arguably, it's the American way.
However, the search for how to make an idea profitable and how the
government can then exert dominion and control over such, typically
stifles creativity, which in turn prohibits innovation, and subsequently
slows progress. The argument is not that this model does not work, but
rather to elucidate the cost-benefit analysis that must occur. The health
care industry is not going anywhere. Its importance is directly correlated to
survival. The tech industry is here to stay as well. Most every faction of
daily life is slowing being infiltrated by new forms of technology. The
intermingling of these two industries will continue, in perpetuity. This is
simply a fact of life in the twenty first century. But, what should not be a
fact of life is the continued governmental intervention at the expense of
ingenuity. Change may be constant, but interference with progress does
not have to be.
The Frank H. Netter, MD School of Medicine at Quinnipiac
University in North Haven, Connecticut welcomed its first class of
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medical students in the fall of 2013.81 In an interview, one professor of the
medical school pointed out that as students began their medical education
at Quinnipiac, they found that the curriculum included learning how to use
medically-related mobile applications in practice. 82 While Quinnipiac may
currently be in the minority of institutions providing this type of education,
the inclusion of mobile medical apps in provider care is only going to
grow. As we face the next set of challenges and begin creating inspired
and inventive responses to tomorrow's health problems, we will face no
bigger hurdle than ourselves. Once we decide to stop being our own worst
enemy, then, and only then, will we be able to become our own greatest
asset.

81 See generally Quinnipiac University Frank H. Netter MD School of Medicine,
http://www.quinnipiac.edu/academics/colleges-schools-and-departments/school-of-medicine/ (last visited
Feb. 26, 2014).
82 Diane Cooper, Understanding the Impact of the FDA Guidancefor Mobile Medical Applications: Is

There an App For That?, 32 QuJNNIPIAc L. REV 95, 95 (2013).

